*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Novel nano-metal complexes of modified aspirin as future antimicrobial agents

Author: ABDOU S.EL-TABL, ABD EL-HAMID ISMAIL, MOSHIRA M.ABD EL-WAHED, REHAM ALI S.AHMED, AHMED.M.ASHOUR
Abstract: Aspirin which was initially developed as an analgesic anti-inflammatory agent has come to be the basis of antiplatelet therapy. It has been reported that, 10-60% of patients on aspirin therapy are resistant to aspirin and such patients are at risk of developing cardio-vascular events, therefore, we tried to modify its structure to be useful for multiple therapeutic effect. New Mn(II), Ni(II), Cu(II), Zn(II) and Cd(II) organo-metallic compounds in nanoform of modified aspirin have been prepared and characterized using elemental and spectral analyses such as IR, UV-VIS, 1H-NMR, mass spectra, ESR as well as conductivity, magnetism, thermal analysis (DTA and TGA) and electron microscope. Elemental and spectral analysis showed, all the complexes were octahedral structure, however, the conductivity measurement confirmed non-electrolytic nature except Cu(II) complex (4). The ESR spectra of solid state at room temperature for Cu(II) complexes (2), (4), (7) had an axial type (dx2-y2) with covalent bond character, Mn(II) complex (14) showed isotropic type with octahedral structure. In vitro antimicrobial screening test for the ligand and some of its complexes showed, for (+ve) (Staphylococcus aureus), the order is ligand (1)> Cd(II) complex (10)> ampicillin> Zn(II) complex (8)> Cu(II) complex (2) = Cu(II) complex (3)> Cu(II) complex (4) = Cu(II) complex (6) = Ni(II) complex (12) > Aspirin > Mn(II) complex (14) and for (-ve) (Escherichia coli), the order is ligand (1)> Cd(II) complex (10)> ampicillin> Zn(II) complex (8)> Cu(II) complex (3)> Cu(II) complex (4)= Cu(II) complex (6)= Ni(II) complex (12)> Cu(II) complex (2)= aspirin> Mn(II) complex (14) and (Aspergillus flavus), the order is Cd(II) complex (10)>amphotericin B> ligand (1) > Cu(II) complex (2) = Cu(II) complex (3) = Cu(II) complex (4) = Cu(II) complex (6) = Zn(II) complex (8)= Ni(II) complex (12)= Mn(II) complex (14) and (candida albicans), the order is amphotericin B > Cd(II) complex (10)>ligand (1)> Ni(II) complex (12)> Cu(II) complex (2)= Cu(II) complex (6)> Cu(II) complex (3)= Cu(II) complex (4) > Zn(II) complex (8)= Mn(II) complex (14). However, invivo studies for above compounds showed no toxicity was observed for all organs tested.
Keyword: Aspirin derivatives, complexes, spectra, antimicrobial activity.
DOI: https://doi.org/10.31838/ijpr/2022.14.01.015
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free